Comparative analysis of patients with colorectal cancer clinically diagnosed in hospitals with those detected by mass screening

Chinese Journal of Gastroenterology

Volumn 9, Issue 3, 2004, Pages 145-149

[No Author Info available]

Author keywords

Clinical features; Colorectal neoplasms; Diagnosis; Mass screening

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CHINA; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASS SCREENING; OCCULT BLOOD; POPULATION RESEARCH; PROGNOSIS; RISK FACTOR;

EID: 3442893654     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chinese source. 2000, 22: 263-264.
2. Chinese source. 2001, 10: 375-376.
3. Chinese source. 1997, 19: 3-9.
4. Chinese source. 2000, 21: 362-365
5. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut, 2002, 50: 29-32.
6. Bretthauer M, Gondal G, Larsen K, Carlsen E, Eide TJ, Grotmol T, Skovlund E, Tveit KM, Vatn MH, Hoff G. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol, 2002, 37: 568-573.
7. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med, 2000, 343: 1603-1607.
8. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut, 2002, 50: 840-844.
9. Chinese source. 1990, 9: 152-154.
10. Chinese source. 2002, 22: 395-397.
11. Chinese source. 1997, 14: 222-224.
12. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology, 2003, 124: 544-560.
13. Petersen VC, Baxter KJ, Love SB, Shepherd NA. Identification of objective pathological prognostic determinants and models of prognosis in Dukes 'B colon cancer. Gut, 2002, 51: 65-69.
14. Lewis JD. Cost-effectiveness of screening for colorectal cancer: the dollar is in the details. Gastroenterology, 2003, 124: 856-858.